Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

Program Overview

Asthma is one of the most common chronic diseases of childhood. While most children achieve asthma control, some develop severe and persistent disease that cannot be controlled with standard treatment options. Evolution in our understanding of asthma biology has led to the development of novel targeted therapies that target the underlying mechanisms of disease, several of which are now available for pediatric patients. This interactive activity combines artistic design, infographic presentation, and scientific expertise to deliver the latest advances in treatment of pediatric asthma, including current treatment guidelines, identifying poorly-controlled disease, and incorporating novel biologic therapy into the management of pediatric patients with asthma.

Credit Expired
CE Credit Expired
Expires: January 29, 2021

Target Audience

This activity is designed for allergy/immunology and pulmonology providers, including physicians, nurse practitioners, and physician assistants who manage pediatric patients with asthma.

Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Incorporate current recommended treatment algorithms into the care of pediatric patients with asthma
  • Identify children with poorly-controlled asthma for whom treatment escalation may be appropriate
  • Integrate newer and more effective treatments for children with resistant or moderate-to-severe asthma based on safety and efficacy data and different asthma endotypes

Activity Faculty

Michael E. Wechsler, MD, MMSc

Michael E. Wechsler, MD, MMSc

Co-Director, The Cohen Family Asthma Institute
Professor, Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources